| Primary |
| Sedation |
35.6% |
| Product Used For Unknown Indication |
19.2% |
| Sedative Therapy |
12.5% |
| Maintenance Of Anaesthesia |
4.8% |
| Extubation |
3.8% |
| General Anaesthesia |
3.8% |
| Drug Use For Unknown Indication |
2.9% |
| Endotracheal Intubation |
2.9% |
| Hypertension |
2.9% |
| Agitation |
1.9% |
| Analgesic Therapy |
1.9% |
| Asthma |
1.0% |
| Bipolar Disorder |
1.0% |
| Blood Calcium |
1.0% |
| Craniotomy |
1.0% |
| Gastrooesophageal Reflux Disease |
1.0% |
| Hyperthyroidism |
1.0% |
| Nuclear Magnetic Resonance Imaging |
1.0% |
| Psychomotor Hyperactivity |
1.0% |
|
| Cardiac Arrest |
9.3% |
| Hypotension |
9.3% |
| Hyperthermia Malignant |
7.0% |
| Rhabdomyolysis |
7.0% |
| Tachycardia |
7.0% |
| Bradycardia |
4.7% |
| Cerebrovascular Accident |
4.7% |
| Off Label Use |
4.7% |
| Pyrexia |
4.7% |
| Restlessness |
4.7% |
| Shock |
4.7% |
| Sinus Arrest |
4.7% |
| Unevaluable Event |
4.7% |
| Unresponsive To Stimuli |
4.7% |
| Upper Airway Obstruction |
4.7% |
| Ventricular Tachycardia |
4.7% |
| Atrial Fibrillation |
2.3% |
| Atrioventricular Block Complete |
2.3% |
| Atrioventricular Block Second Degree |
2.3% |
| Blood Pressure Decreased |
2.3% |
|
| Secondary |
| Product Used For Unknown Indication |
50.0% |
| Ill-defined Disorder |
17.6% |
| Infection |
5.6% |
| Pyrexia |
5.0% |
| Constipation |
4.8% |
| Anaesthesia |
4.5% |
| Sedation |
3.4% |
| Induction Of Anaesthesia |
1.6% |
| Maintenance Of Anaesthesia |
1.1% |
| Epidural Anaesthesia |
0.9% |
| Insomnia |
0.9% |
| Pain |
0.9% |
| Hypotonia |
0.8% |
| Diuretic Therapy |
0.6% |
| General Anaesthesia |
0.6% |
| Analgesic Therapy |
0.3% |
| Catatonia |
0.3% |
| Fungal Infection |
0.3% |
| Neuroleptic Malignant Syndrome |
0.3% |
| Premedication |
0.3% |
|
| Drug Rash With Eosinophilia And Systemic Symptoms |
47.2% |
| Respiratory Depression |
9.4% |
| Drug Reaction With Eosinophilia And Systemic Symptoms |
7.5% |
| Hypotension |
3.8% |
| Neuroleptic Malignant Syndrome |
3.8% |
| Polyuria |
3.8% |
| Tachypnoea |
3.8% |
| Blood Pressure Immeasurable |
1.9% |
| Cardiac Arrest |
1.9% |
| Constipation |
1.9% |
| Lymphocyte Stimulation Test Positive |
1.9% |
| Purpura |
1.9% |
| Renal Impairment |
1.9% |
| Respiratory Gas Exchange Disorder |
1.9% |
| Sedation |
1.9% |
| Septic Shock |
1.9% |
| Upper Airway Obstruction |
1.9% |
| Urine Colour Abnormal |
1.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
54.9% |
| Prophylaxis |
10.6% |
| Drug Use For Unknown Indication |
5.6% |
| Bone Marrow Conditioning Regimen |
3.9% |
| Sedation |
3.0% |
| Premedication |
2.6% |
| Gastritis Prophylaxis |
2.3% |
| Prophylaxis Against Graft Versus Host Disease |
1.9% |
| Infection Prophylaxis |
1.7% |
| Endotracheal Intubation |
1.6% |
| Antifungal Prophylaxis |
1.4% |
| Maintenance Of Anaesthesia |
1.4% |
| General Anaesthesia |
1.3% |
| Antiviral Prophylaxis |
1.2% |
| Aplastic Anaemia |
1.2% |
| Prophylaxis Of Nausea And Vomiting |
1.2% |
| Antibiotic Prophylaxis |
1.0% |
| Bacterial Infection |
1.0% |
| Hypertension |
1.0% |
| Multiple Myeloma |
1.0% |
|
| Rhabdomyolysis |
13.2% |
| Suicide Attempt |
10.5% |
| Cerebral Infarction |
7.9% |
| Pulmonary Alveolar Haemorrhage |
7.9% |
| Ventricular Tachycardia |
7.9% |
| Anaesthetic Complication Neurological |
5.3% |
| Injury |
5.3% |
| Sepsis |
5.3% |
| Swelling |
5.3% |
| Transplant Rejection |
5.3% |
| Acute Respiratory Distress Syndrome |
2.6% |
| Blood Glucose Increased |
2.6% |
| Death |
2.6% |
| Diarrhoea |
2.6% |
| Disease Progression |
2.6% |
| Disseminated Intravascular Coagulation |
2.6% |
| Drug-induced Liver Injury |
2.6% |
| Electromechanical Dissociation |
2.6% |
| Gastrointestinal Haemorrhage |
2.6% |
| Graft Versus Host Disease In Skin |
2.6% |
|
| Interacting |
| Sedation |
33.3% |
| Blood Pressure Fluctuation |
20.0% |
| Maintenance Of Anaesthesia |
20.0% |
| Induction Of Anaesthesia |
13.3% |
| Hypothyroidism |
6.7% |
| Hypotonia |
6.7% |
|
| Pyrexia |
50.0% |
| Respiratory Depression |
50.0% |
|
